Ibere Pharmaceuticals – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/22 Q3

ended 06/30/22 Q2

ended 03/31/22 Q1

ended 12/31/21 FY 2021

ended 09/30/21 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Registration of securities on exchange

Ownership Filter

Citadel Advisors LLC

Glazer Capital, LLC

Hudson Bay Capital Management LP

Hartree Partners, LP

Magnetar Financial LLC

News Filter

Announces Redemption of Public Shares and Subsequent Dissolution

Index to Financial Statement

Non-Reliance on Previously Issued Financial Statements or Related Audit Report or Completed Interim Review

Change in Certifying Accountant, Financial Statements or Exhibits

Receives Expected NYSE Notice Regarding Delayed Quarterly Report

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC